Ekso Bionics Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Ekso Bionics Holdings generated cash of -$12,054,000, which is more than the previous year. Cash used in financing activities reached the amount of $348,000 last year. Net change in cash is therefore -$11,887,000.
Cash Flow
| 2014 | -15.00M | -1.48M | 40.87M |
|---|---|---|---|
| 2015 | -18.26M | -1.49M | 14.12M |
| 2016 | -24.99M | -1.09M | 23.30M |
| 2017 | -31.22M | -456K | 42.56M |
| 2018 | -22.16M | -131K | 2.27M |
| 2019 | -15.77M | -60K | 19.03M |
| 2020 | -8.75M | 0 | 10.70M |
| 2021 | -11.15M | -59K | 38.71M |
| 2022 | -14.68M | -5.17M | 176K |
| 2023 | -12.05M | -157K | 348K |
EKSO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 20.52M | 40.40M | 12.86M | 10.87M | 7.65M | 27.81M | 16.84M | 19.55M | 25.19M | 805K |
Operating activities | ||||||||||
Net income | -15.19M | -15.08M | -9.76M | -15.82M | -12.13M | -26.99M | -29.12M | -23.47M | -19.59M | -33.76M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.69M | 887K | 561K | 620K | 690K | 1.51M | 1.73M | 1.85M | 933K | 745K |
Stock-based compensation expense | 2.23M | 2.73M | 2.5M | 2.57M | 2.39M | 3.08M | 2.92M | 3.12M | 1.73M | 1.14M |
| Deferred income tax benefit | 2.23M | 2.73M | 2.5M | 2.57M | 2.39M | 3.08M | 2.92M | 3.12M | 1.73M | 1.14M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.20M | -67K | -1.62M | 1.75M | -1.59M | -850K | -1.08M | 154K | -520K | -1M |
Inventories | 232K | -1.4M | -752K | 379K | 893K | -1.65M | -2.09M | -541K | -200K | 354K |
Accounts payable | -1.30M | -102K | 1.61M | -402K | -1.23M | 752K | 77K | -818K | 1.73M | -716K |
Cash generated by operating activities | -12.05M | -14.68M | -11.15M | -8.75M | -15.77M | -22.16M | -31.22M | -24.99M | -18.26M | -15.00M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -157K | -194K | -59K | 0 | -60K | -131K | -456K | -1.09M | -1.49M | -1.48M |
Acquisitions Net | 0 | -5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -157K | -5.17M | -59K | 0 | -60K | -131K | -456K | -1.09M | -1.49M | -1.48M |
Financing activities | ||||||||||
Common Stock Issued | 661K | 176K | 37.29M | 7.08M | 21.18M | 4.44M | 42.46M | 14.69M | 0 | 21.96M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.34M | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -173K | 0 | 0 |
Repayments of term debt | -313K | 0 | 0 | -2.79M | -2.37M | -2.17M | -54K | -79K | -60K | -2.59M |
Cash used in financing activities | 348K | 176K | 38.71M | 10.70M | 19.03M | 2.27M | 42.56M | 23.30M | 14.12M | 40.87M |
Net Change In Cash | -11.88M | -19.88M | 27.54M | 1.99M | 3.21M | -20.15M | 10.96M | -2.70M | -5.63M | 24.38M |
Cash at end of period | 8.63M | 20.52M | 40.40M | 12.86M | 10.87M | 7.65M | 27.81M | 16.84M | 19.55M | 25.19M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |